Disease severity, quality of life and health care in plaque-type psoriasis:: A multicenter cross-sectional study in Germany

被引：203

作者：

Augustin, M. ^{[1
]}

Krueger, K.

Radtke, M. A. ^{[1
]}

Schwippl, I. ^{[3
]}

Reich, K. ^{[2
]}

机构：

[1] Univ Clin Hamburg, Dept Dermatol, Hlth Econ & Qual Life Res Grp, DE-20246 Hamburg, Germany

[2] Dermatologikum Hamburg, Hamburg, Germany

[3] Essex Pharma GmbH, Munich, Germany

来源：

DERMATOLOGY | 2008年 / 216卷 / 04期

关键词：

dermatology life quality index; plaque-type psoriasis; psoriasis area and severity index; quality of life;

D O I：

10.1159/000119415

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background: Plaque-type psoriasis produces significant morbidity, has negative effects on patients' health-related quality of life (HRQoL), and represents an economic burden. Objectives: The assessment of disease severity, HRQoL and health care in plaque-type psoriasis in everyday German medical practice. Methods: Details of patients with plaque-type psoriasis were recorded by 48 dermatologists in Germany. During the visit, demographic data, medical history, previous and current treatments, occupational impairment, the current state of the disease (measured by the Psoriasis Area and Severity Index; PASI), overall lesion severity, and HRQoL were evaluated. Results: In total, 1,511 plaque-type psoriasis patients were included. The average PASI score was 12.0. The average Dermatology Life Quality Index score was 8.6. Among the patients with the severest psoriasis (PASI > 20), only 45.4% had ever been prescribed systemic treatments. Conclusions: Psoriasis patients have a reduced HRQoL and are not sufficiently treated in practice. A more widespread use of systemic treatment and the definition of treatment goals are essential to improve the standard of care for psoriasis patients. Copyright (c) 2008 S. Karger AG, Basel.

引用

页码：366 / 372

页数：7

共 42 条

[11]

FINLAY AY, 1995, BRIT J DERMATOL, V132, P236

[12] QUALITY-OF-LIFE MEASURES IN HEALTH-CARE .1. APPLICATIONS AND ISSUES IN ASSESSMENT [J].

FITZPATRICK, R ;

FLETCHER, A ;

GORE, S ;

JONES, D ;

SPIEGELHALTER, D ;

COX, D .

BRITISH MEDICAL JOURNAL, 1992, 305 (6861) :1074-1077

[13] ORAL TREATMENT OF PUSTULOSIS PALMO-PLANTARIS WITH A NEW RETINOID, RO-10-9359 [J].

FREDRIKSSON, T ;

PETTERSSON, U .

DERMATOLOGICA, 1979, 158 (01) :60-+

[14] TRIVIAL OR TERRIBLE - THE PSYCHOSOCIAL IMPACT OF PSORIASIS [J].

FRIED, RG ;

FRIEDMAN, S ;

PARADIS, C ;

HATCH, M ;

LYNFIELD, Y ;

DUNCANSON, C ;

SHALITA, A .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (02) :101-105

[15] A single European currency for EQ-5D health statesResults from a six-country study [J].

Wolfgang Greiner ;

Tom Weijnen ;

Martin Nieuwenhuizen ;

Siem Oppe ;

Xavier Badia ;

Jan Busschbach ;

Martin Buxton ;

Paul Dolan ;

Paul Kind ;

Paul Krabbe ;

Arto Ohinmaa ;

David Parkin ;

Montserat Roset ;

Harri Sintonen ;

Aki Tsuchiya ;

Frank de Charro .

The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (3) :222-231

[16] MEASURING HEALTH-RELATED QUALITY-OF-LIFE [J].

GUYATT, GH ;

FEENY, DH ;

PATRICK, DL .

ANNALS OF INTERNAL MEDICINE, 1993, 118 (08) :622-629

[17] Patients' and doctors' assessment of skin disease handicap [J].

Hermansen, SE ;

Helland, CA ;

Finlay, AY .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2002, 27 (03) :249-250

[18] The direct cost of care for psoriasis and psoriatic arthritis in the United States [J].

Javitz, HS ;

Ward, MM ;

Farber, E ;

Nail, L ;

Vallow, SG .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (06) :850-860

[19] Health status of the German population:: Results of a representative survey using the EuroQol questionnaire [J].

König, HH ;

Bernert, S ;

Angermeyer, MC .

GESUNDHEITSWESEN, 2005, 67 (03) :173-+

[20]

Krueger G, 2001, ARCH DERMATOL, V137, P280

← 1 2 3 4 5 →